logo
Select company
Select metric
$ -315.19MNet Income Common Stock
VS
Market
4
Sector
6
Industry
6
History
93
$ 13.63Close
$ 5.57 - $ 16.36 52-Week Range
Ticker Information

Ticker

DNA

Company Name

GINKGO BIOWORKS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

GINKGO BIOWORKS HOLDINGS INC - Net Income Common Stock Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DNA - Net Inc. Cmn. Historical data
DateNet Income Common Stock
6/30/2025$ -315.19M
3/31/2025$ -472.07M
12/31/2024$ -547.03M
9/30/2024$ -651.19M
6/30/2024$ -897.68M
3/31/2024$ -853.81M
12/31/2023$ -892.87M
9/30/2023$ -857.72M
6/30/2023$ -1.22B
3/31/2023$ -1.72B
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GINKGO BIOWORKS HOLDINGS INC's latest trailing twelve months (TTM) Net Inc. Cmn. stands at $ -231.13M.
  • Over the past 5 years, GINKGO BIOWORKS HOLDINGS INC's average Net Inc. Cmn. has been $ -1.34B.
  • The median Net Inc. Cmn. for GINKGO BIOWORKS HOLDINGS INC during this period was $ -895.27M
  • GINKGO BIOWORKS HOLDINGS INC reached its highest Net Inc. Cmn. over the past 5 years at $ -231.13M.
  • The lowest Net Inc. Cmn. recorded by GINKGO BIOWORKS HOLDINGS INC in the same timeframe $ -3.53B

GINKGO BIOWORKS HOLDINGS INC's Net Inc. Cmn. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. Cmn. Benchmarks
CompanyNet Inc. Cmn.
AKBA : AKEBIA THERAPEUTICS INC $ -36.48MSTOK : STOKE THERAPEUTICS INC $ 52.48MIOVA : IOVANCE BIOTHERAPEUTICS INC $ -389.92MKROS : KEROS THERAPEUTICS INC $ 18.77MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ -95MGERN : GERON CORP $ -88.01MRCUS : ARCUS BIOSCIENCES INC $ -298MXERS : XERIS BIOPHARMA HOLDINGS INC $ -32MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -194.72MCRMD : CORMEDIX INC $ 51.16M

Similar metrics to Net Inc. Cmn.:

Definition of Net Income Common Stock

[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].

DNA - Net Income Common Stock, Last 5 years

$ -3.53B

Minimum

Sep 30, 2022

$ -231.13M

Maximum

Sep 30, 2021

$ -1.34B

Average

$ -895.27M

Median

Net Inc. Cmn. Benchmark Analysis

 The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 9.25M with a standard deviation of $ 113.61M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
filtered constituents3.37K
min$ -354.46M
max$ 366.43M
average$ 9.25M
median$ -2.46M
std$ 113.61M